Sahm Adrangi Is Taking The Short Side With Proteostasis With Latest Negative Report From Kerrisdale

Sahm Adrangi is a well-known man in the investing world thanks to his many accomplishments as an investor and his success at Kerrisdale Capital. This private investment firm invests in various companies around the world. Today, being able to identify quality companies in the stock market is a challenge, and Sahm Adrangi is standing out where not many can. Kerrisdale has managed to excel and come out on top of the S&P 500 for several successive quarters.

On a normal basis, Kerrisdale Capital puts out reports on various companies in the market, and their latest was quite the negative report against biotech firm Proteostasis. This biotech company is home to Cambridge and has recently been making claims of a new breakthrough in terms of cystic fibrosis. Their new drug in development, PTI-428, is aimed at helping increasing lung performance in patients.

Unfortunately for Proteostasis, Kerrisdale was not impressed with their figures and the data they released, so Sahm Adrangi decided to do a little more digging into the company. Upon even closer examination of the results of the company, their actual test sample was extremely small. So small in fact, PTI-428 was only tested on four patients. This is not nearly enough to make such claims the company has been making, causing their company stock value to go up.

Kerrisdale took quickly to their report to get it out as soon as possible to inform the public and many investors out there of what is really behind this biotech company, Proteostasis. According to Sahm Adrangi, their drug cocktail is most likely an ineffective drug that works better as a placebo. Unfortunately for Proteostasis, the majority of their company value is invested in their product, which means they will lose more than 70% of their company share value when it comes out that PTI-428 is not effective.

As more companies and investors are becoming aware of the nature of this biotech company, their share values continue to drop and will likely push the company off the map in the near future.

http://www.imdb.com/name/nm1444924/

April 19, 2018

Posted In: Business, Business success, Businessman, CEO, Entrepreneur, Investor

Tags: , , , , , , , , ,

Tempus Technologies of Eric Lefkofky Receives $ 80 Million

The name Eric Lefkofsky is trending because of some noble actions of the great inventor and technology geek. Eric is the CEO of Tempus; a technology outfit that has hit the news for months about its efforts to battle cancer by using cutting-edge technologies. He is also a co-founder of the company and a couple of others in the technology field. Eric is so conspicuous because of his liking for disruptive technologies that help enhance service delivery, especially in the health services sector. Eric also co-founded a NASDAQ-listed company by the name Groupon. The list of the tech companies Eric has helped to start or started on his own is long, but one of the most outstanding because of the contribution it has already made in the fight against cancer is Tempus. It is an operating system that uses personalized patient data to develop profiles and analysis of a patient’s cancer status and trends. Physicians have found the technology handy because it helps them make fast decisions about the cancer patients that they interact with; decisions that are often helpful in battling cancer before the condition spread its ominous tentacles too far. Tempus has already networked with many cancer centers in the US. Now it is getting some money for growth.

Tempus Receives More Donor Funding

According to reports by the Chicago Tribune recently, Mr. Eric Lefkofsky’s Tempus Company has just received a cash boost. It will be yet another gesture of support for the work by the young American inventor and technology enthusiast who uses his passion and skills in technology to promoter cancer treatment and handling. Tempus is noted to be an important resource in promoting upcoming technologies that prove to have the potential to change the old order of things, especially in the medical world. According to the Chicago Tribune report, Tempus has received over $ 80 million from what the news source describes as existing and new investors. So far, Tempus, under the umbrella of Groupon has received up to $210 million since it was started in 2015. Tempus breaks the record of companies that have had the most profound impact on humanity barely two years since they were started. The latest funding is a boost to Mr. Eric Lefkofky’s work in battling the cancer menace through technology. To know more about him click here.

His Contributions to Society

Eric Lefkofsky has demonstrated a heart for helping those who have been afflicted by disease and pain. He and his wife formed the Lefkofsky Family Foundation. The Foundation seeks to extend charity assistance to needy communities and individuals around the globe to resolve or mitigate their health concerns. Eric is a respected personality already. He is a trustee of Lurie Children’s Hospital based in Chicago, the Museum of Science among others.

April 3, 2018

Posted In: Businessman, CEO

Tags:

Desiree Perez Brings Financial Security to Roc Nation

Across the world, the Roc Nation brand has been growing in importance for fans and partners of the business created by rapper, Jay-Z. One of the major players in the development of Roc Nation is Desiree Perez, a long-time business partner of Jay-Z who has spent much of her time looking to develop the business relationships which have proven so important to the brand. Roc Nation is now one of the leading recording labels in the world with a long history of support from many of the best-known businesses on the planet who appeal to the key demographic of the company.

Among the many companies, Roc Nation has partnered with is the telecom giant, Sprint which has chosen to become one of the main investors in the Tidal streaming service to the tune of $200 million. Roc Nation has grown to become an important part of the entertainment industry in a range of different sectors where Desiree Perez has spent her time exploring the many deals and partnerships on offer for the brand; one of the most important aspects of the work of Roc Nation has been the link between the label and its parent company, Live Nation which has provided around $300 million in investment capital over the last decade.

Desiree Perez has become such a trusted member of the Roc Nation team because she was already known to Jay-Z for her business skills from her years working with the SC Enterprises company. The majority of the work completed by Desiree Perez was kept out of the spotlight until the renegotiation period for the Roc Nation deal with Live Nation when the executive was pictured looking for new investment from the Universal Music Group which eventually signed a music distribution deal with the label.

Facebook: https://www.facebook.com/public/Desiree-Perez

December 22, 2017

Posted In: CEO